Over 1,000 Patients Enrolled in Landmark SELUTION DeNovo Study
GENEVA, March 15, 2023 /PRNewswire/ — MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized
Read MoreGENEVA, March 15, 2023 /PRNewswire/ — MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized
Read MoreThe multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare
Read MoreGENEVA, Jan. 26, 2023 /PRNewswire/ — The first US patient has been enrolled at MedStar Washington Hospital Center in the
Read MoreGENEVA, Switzerland, Sept. 10, 2022 /PRNewswire/ — An 82-year-old Taiwanese man has become the first patient to be enrolled in
Read MoreGENEVA, Switzerland, Aug. 24, 2022 /PRNewswire/ — The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial
Read MoreGREENWOOD VILLAGE, Colo. and LOS ANGELES, July 26, 2022 /PRNewswire/ — ANANDA Scientific Inc., a research focused bio-pharmaceutical company today
Read MoreTEL AVIV, Israel, July 13, 2022 /PRNewswire/ — SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS™)
Read MoreLEIPZIG, Germany, June 8, 2022 /PRNewswire/ — The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK
Read More